EP 1651215 A1 20060503 - TRANSDERMALTHERAPEUTIC SYSTEM CONTAINING A PRAMIPEXOL ACTIVE AGENT
Title (en)
TRANSDERMALTHERAPEUTIC SYSTEM CONTAINING A PRAMIPEXOL ACTIVE AGENT
Title (de)
TRANSDERMALES THERAPEUTISCHES SYSTEM MIT DEM WIRKSTOFF PRAMIPEXOL
Title (fr)
SYSTEME THERAPEUTIQUE TRANSDERMIQUE CONTENANT LE PRINCIPE ACTIF PRAMIPEXOL
Publication
Application
Priority
- EP 2004007770 W 20040714
- DE 10333393 A 20030723
Abstract (en)
[origin: WO2005011687A1] The invention relates to a transdermal therapeutic system (TTS) releasing an active pramipexol agent during a time ranging from 4 to 7 hours.
IPC 1-7
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/428 (2006.01)
CPC (source: EP KR US)
A61K 9/70 (2013.01 - KR); A61K 9/7061 (2013.01 - EP US); A61K 31/428 (2013.01 - EP KR US); A61P 3/04 (2017.12 - EP); A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 21/04 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/14 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/30 (2017.12 - EP)
Citation (search report)
See references of WO 2005011687A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005011687 A1 20050210; AU 2004260583 A1 20050210; AU 2004260583 B2 20100128; BR PI0412240 A 20060912; CA 2532904 A1 20050210; CN 100450482 C 20090114; CN 1826113 A 20060830; DE 10333393 A1 20050224; EP 1651215 A1 20060503; JP 2006528144 A 20061214; JP 4925823 B2 20120509; KR 20060113638 A 20061102; US 2006182791 A1 20060817; US 2012225103 A1 20120906; ZA 200600206 B 20070228
DOCDB simple family (application)
EP 2004007770 W 20040714; AU 2004260583 A 20040714; BR PI0412240 A 20040714; CA 2532904 A 20040714; CN 200480021039 A 20040714; DE 10333393 A 20030723; EP 04740987 A 20040714; JP 2006520736 A 20040714; KR 20067001495 A 20060123; US 201213473724 A 20120517; US 56493204 A 20040714; ZA 200600206 A 20060109